Reactivation of type 1 diabetes in patients receiving human fetal pancreatic tissue transplants without immunosuppression

Transplantation

Volumn 69, Issue 1, 2000, Pages 166-172

  Brooks Worrell, Barbara M ^a,b   Peterson, Karen P ^c,d   Peterson, Charles M ^c   Palmer, Jerry P ^a,b   Jovanovic, Lois ^c  

^a Puget Sound Health Care System   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^d Bldg 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; FEMALE; FETUS; GRAFT REJECTION; HUMAN; IMMUNOBLOTTING; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONONUCLEAR CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0034650768     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001150-00028     Document Type: Article

References (33)

1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619.
2. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983; 24: 366.
3. Palmer JP. Predicting IDDM: use of humoral immune markers. Diabetes Rev 1993; 1: 104.
4. Greenbaum CJ, Brooks-Worrell BM, Palmer JP, Lernmark A. Autoimmunity and prediction of insulin dependent diabetes mellitus. In: Marshall SM, Home PD, eds. Diabetes Annual 8. New York: Elsevier Science BV, 1994: 21.
5. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Botazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701.
6. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 1996; 157: 5668.
7. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, DeVries RRP. T-cell reactivity to beta-cell membrane antigens associated with beta cell destruction in IDDM. Diabetes 1995; 44: 278.
8. Durinovic-Bellò I, Hummel M, Ziegler A-G. Cellular immune response to diverse antigens in IDDM. Diabetes 1996; 45: 795.
9. Brooks-Worrell B, Gersuk V, Greenbaum C, Palmer JP. Intermolecular antigen spreading occurs during the pre-clinical period of type 1 diabetes. J Invest Med 1998; 46: 91A.
10. Durinovic-Bellò I, Ziegler A-G. Autoantigen and T-cell-epitope spreading in type 1 diabetes. Diabetes 1998; 47(Supp 1): A235.
11. Kawasaki E, Yu L, Rewers MJ, Hutton JC, Eisenbarth GS. Definition of multiple ICA512/Phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes. Diabetes 1998; 47: 733.
12. Naserke HE, Ziegler A-G, Lampasona V, Bonifacio E. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol 1999; 161: 6963.
13. Feldmann M, Dayan C, Rapoport B, Londei M. T cell activation and antigen presentation in human thyroid autoimmunity. Autoimmunity 1992; 5: 115.
14. VanNoort JM, Van Sechel A, Boon J, Boersma WJA, Polman CH, Lucan CJ. Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjects. J Neuroimmunol 1993; 46: 67.
15. Freeman M, Weetman AP. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin Exp Immunol 1992; 88: 275.
16. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995; 182: 75.
17. Javonovic-Peterson L, Williams K, Brennan M, Rashbaum W, Peterson CM. Studies of human fetal pancreatic allografts in diabetic recipients without immunosuppression. J Diabet Complications 1989; 3: 27.
18. Gelber C, Paborsky L, Singer S, et al. Isolation of nonobese diabetic mouse T cells that recognize novel autoantigens involved in the early events of diabetes. Diabetes 1994; 43: 33.
19. Brooks-Worrell B, Juneja R, Mionokadeh A, Greenbaum CJ, Palmer JP. Cellular immune responses to human islet proteins in antibody positive type 2 subjects. Diabetes 1999; 48: 983.
20. Brooks-Worrell B, Splitter GA. Brucella abortus strain 19 antigens immunodominant for bovine lymphocytes as identified by one-and two-dimensional cellular immunoblotting. Infect Immun 1992; 60: 2459.
21. Brooks-Worrell B, Splitter GA. Sodium dodecyl sulfate and salt extracted antigens from various Brucella species induce proliferation of bovine lymphocytes. Infect Immun 1992; 60: 2136.
22. Brooks-Alder B, Splitter GA. Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus using protein immunoblotting. Infect Immun 1988; 56: 2581.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 6880.
24. Abou-Zeid C, Filley E, Steele J, Rook BAW. A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods 1987; 98: 5.
25. 3H recombinant human ligands. J Immunol Methods 1995; 196; 89.
26. 1 mice with bone marrow cells from NOD mice. J Exp Med 1988; 167: 1801.
27. Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989; 38: 85.
28. Sibley RK, Sutherland DER, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso-and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53: 132.
29. Stegall MD, Lafferty KJ, Kam I, Gill RG. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 1995; 61: 1272.
30. Tyden G, Reinhold FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860.
31. Esmatjes E, Rodriguez-Villar C, Ricart MJ, et al. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 1998; 66: 128.
32. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 1997; 46: 1907.
33. Roep BO, Stobbe I, Duinkerken G, et al. Auto-and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999; 48: 484.